Why the study?
Obstructive hypertrophic cardiomyopathy during pregnancy is associated with significant maternal and perinatal morbidity, with risks higher in symptomatic women or those with severe LV outflow tract obstruction.
Case Report
Supports individualized monitoring for symptomatic obstructive HCM in pregnancy; leaves open arrhythmia incidence and optimal strategies from Level 5 data.
Obstructive hypertrophic cardiomyopathy (HCM) during pregnancy is associated with significant maternal and perinatal morbidity. Physiological changes during pregnancy can induce complications: sudden death, heart failure and arrhythmia involving the maternal and fetal prognosis. Women with HCM generally tolerate pregnancy well. The risk is however higher in women who are symptomatic before pregnancy or in those with severe left ventricular outflow tract obstruction. The incidence of arrhythmias does not appear to be increased during pregnancy and maternal mortality is low. Prior to conception, women with HCM should have a risk assessment as well as genetic counseling. A vaginal delivery with regional anesthesia is usually appropriate. Women should be managed by a specialist multidisciplinary team.
No takes yet. Share an insight, caveat, or question.
Yousra Oussou (2021) conducted a case report in Obstructive hypertrophic cardiomyopathy (HCM) during pregnancy. Pregnancy in women with obstructive HCM was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: